Biopharma In China The Emerging Global Force Of Domestic Suppliers
A major factor in the emerging domestic competition is the Chinese drug industry’s response to cost pressures being implemented, such as the...
Stay updated with breaking news from Vicky Xia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A major factor in the emerging domestic competition is the Chinese drug industry’s response to cost pressures being implemented, such as the...
Just as the U.S. and European bioprocessing supply systems have seen more robust growth than ever before, China’s domestic demands for...
Just as the U.S. and European bioprocessing supply systems have seen more robust growth than ever before, China’s domestic demands for...
CPhI survey: pharma leaders optimistic about the future According to a recent survey of executives conducted by CPhI, COVID-19’s impact is driving manufacturing and CDMOs are fueling industry growth. CPhI has released a survey taking the post-pandemic temperature pharmaceutical leaders, gauging how they feel about the industry’s prospects in the immediate and medium-term future. The findings in the report (to be outlined in a May 20 session during the organization’s virtual CPhI Discover event) reveal companies and governmental bodies alike are keenly interes...